The first part of this trial, the dose escalation, is covered by the funds raised in November last year.
- Forums
- ASX - By Stock
- ATX
- Ann: Type D Meeting Outcome With US Food And Drug Administration
ATX
amplia therapeutics limited
Add to My Watchlist
10.3%
!
21.5¢

Ann: Type D Meeting Outcome With US Food And Drug Administration, page-11
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
21.5¢ |
Change
0.020(10.3%) |
Mkt cap ! $77.59M |
Open | High | Low | Value | Volume |
19.0¢ | 21.5¢ | 19.0¢ | $514.6K | 2.576M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 101845 | 21.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.5¢ | 209217 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 69192 | 0.205 |
7 | 73404 | 0.200 |
5 | 203852 | 0.195 |
10 | 201503 | 0.190 |
4 | 212821 | 0.185 |
Price($) | Vol. | No. |
---|---|---|
0.210 | 164450 | 4 |
0.215 | 180904 | 8 |
0.220 | 505141 | 6 |
0.225 | 180540 | 4 |
0.230 | 209210 | 5 |
Last trade - 15.31pm 27/06/2025 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online